Oct 08, 2018
Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV® (telavancin) at IDWeek(TM) 2018
Oct 04, 2018
Acurx Pharmaceuticals to Enter Clinical Trials with First-In-Class Antibiotics to Treat Selected Gram-Positive Bacterial Infections
Oct 01, 2018
Theravance Biopharma to Present New Data from Multiple Studies of VIBATIV® (telavancin) at IDWeek(TM) 2018
Sep 20, 2018
Magnolia Medical Receives Innovative Technology Contract from Vizient, Inc. for Steripath Gen2 Initial Specimen Diversion Device
Aug 28, 2018
Hydromorphone, Vancomycin and Magnesium Sulfate Now Available from Pentec Health
May 24, 2018
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
Apr 02, 2018
CutisPharma Announces Launch Of FIRVANQ(TM) (vancomycin hydrochloride) For Oral Solution
Feb 13, 2018
Magnolia Medical Awarded VA Federal Supply Contract for Steripath
Jan 29, 2018
CutisPharma Announces FDA Approval Of FIRVANQ(TM) For Treatment Of Clostridium Difficile Associated Diarrhea (CDAD) And Staphylococcus Aureus Colitis
Oct 31, 2017
Theravance Biopharma Reports Positive New VIBATIV® (telavancin) Data from TOUR(TM) Observational Patient Registry at 2017 CHEST Annual Meeting
Oct 24, 2017
Theravance Biopharma to Present New Data from Studies of VIBATIV® (telavancin) and Revefenacin (TD-4208) at the 2017 CHEST Annual Meeting
Oct 03, 2017
Theravance Biopharma to Present New Data from Multiple Studies of VIBATIV® (telavancin) at IDWeek(TM) 2017